Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study

Aims: Freezing of gait is a disabling symptom in advanced Parkinson's disease. Positive effects have been suggested with MAO-B inhibitors. We report on an open label clinical study on the efficacy of rasagiline as add-on therapy on freezing of gait and quality of life in patients with Parkinson...

Full description

Bibliographic Details
Main Authors: František Cibulcik, Jan Benetin, Egon Kurca, Milan Grofik, Miloslav Dvorak, Denis Richter, Vladimir Donath, Jan Kothaj, Michal Minar, Peter Valkovic
Format: Article
Language:English
Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2016-12-01
Series:Biomedical Papers
Subjects:
Online Access:https://biomed.papers.upol.cz/artkey/bio-201604-0015_Effects_of_rasagiline_on_freezing_of_gait_in_Parkinson_s_disease_-_an_open-label_multicenter_study.php
id doaj-511cfe65c72d4f668bf47a345f017e92
record_format Article
spelling doaj-511cfe65c72d4f668bf47a345f017e922020-11-25T01:20:26ZengPalacký University Olomouc, Faculty of Medicine and DentistryBiomedical Papers1213-81181804-75212016-12-01160454955210.5507/bp.2016.023bio-201604-0015Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter studyFrantišek Cibulcik0Jan Benetin1Egon Kurca2Milan Grofik3Miloslav Dvorak4Denis Richter5Vladimir Donath6Jan Kothaj7Michal Minar8Peter Valkovic9Department of Neurology, Faculty of Medicine, Slovak Medical University in Bratislava and University Hospital Bratislava, Slovak RepublicDepartment of Neurology, Faculty of Medicine, Slovak Medical University in Bratislava and University Hospital Bratislava, Slovak RepublicDepartment of Neurology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin and University Hospital Martin, Slovak RepublicDepartment of Neurology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin and University Hospital Martin, Slovak RepublicDepartment of Neurology, Hospital Spisska Nova Ves, Slovak RepublicDepartment of Neurology, University Hospital Bratislava, Slovak RepublicDepartment of Neurology, Slovak Health University, Roosevelt Hospital Banska Bystrica, Slovak RepublicDepartment of Neurology, Slovak Health University, Roosevelt Hospital Banska Bystrica, Slovak RepublicSecond Department of Neurology, Faculty of Medicine, Comenius University in Bratislava, Slovak RepublicSecond Department of Neurology, Faculty of Medicine, Comenius University in Bratislava, Slovak RepublicAims: Freezing of gait is a disabling symptom in advanced Parkinson's disease. Positive effects have been suggested with MAO-B inhibitors. We report on an open label clinical study on the efficacy of rasagiline as add-on therapy on freezing of gait and quality of life in patients with Parkinson's disease. Methods: Forty two patients with freezing of gait were treated with 1 mg rasagiline daily as an add-on therapy. Patients were assessed at baseline and after 1, 2 and 3 months of treatment. Freezing of gait severity was assessed using the Freezing of Gait Questionnaire, motor impairment by the modified MDS UPDRS part III, and quality of life using the PDQ-39 questionnaire. Results: Patients treated with rasagiline had a statistically significant decrease in FoG-Q score and modified MDS UPDRS score after 1, 2 and 3 months of therapy. A moderately strong (r = 0.686, P = 0.002) correlation between the effects on mobility and freezing of gait was found. We also observed a statistically significant improvement in global QoL and in the subscales mobility, ADL, stigma and bodily discomfort in patients after 3 months of rasagiline therapy. A significant correlation (r = 0.570, P = 0.02) between baseline FoG-Q score and the baseline score for the PDQ Mobility subscale was found. Conclusion: In our study rasagiline as add-on antiparkinsonian therapy significantly improved mobility, freezing of gait and quality of life. The positive effect on freezing of gait appears to be related to improvement of mobility.https://biomed.papers.upol.cz/artkey/bio-201604-0015_Effects_of_rasagiline_on_freezing_of_gait_in_Parkinson_s_disease_-_an_open-label_multicenter_study.phpparkinson's diseasefreezing of gaitrasagiline
collection DOAJ
language English
format Article
sources DOAJ
author František Cibulcik
Jan Benetin
Egon Kurca
Milan Grofik
Miloslav Dvorak
Denis Richter
Vladimir Donath
Jan Kothaj
Michal Minar
Peter Valkovic
spellingShingle František Cibulcik
Jan Benetin
Egon Kurca
Milan Grofik
Miloslav Dvorak
Denis Richter
Vladimir Donath
Jan Kothaj
Michal Minar
Peter Valkovic
Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study
Biomedical Papers
parkinson's disease
freezing of gait
rasagiline
author_facet František Cibulcik
Jan Benetin
Egon Kurca
Milan Grofik
Miloslav Dvorak
Denis Richter
Vladimir Donath
Jan Kothaj
Michal Minar
Peter Valkovic
author_sort František Cibulcik
title Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study
title_short Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study
title_full Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study
title_fullStr Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study
title_full_unstemmed Effects of rasagiline on freezing of gait in Parkinson's disease - an open-label, multicenter study
title_sort effects of rasagiline on freezing of gait in parkinson's disease - an open-label, multicenter study
publisher Palacký University Olomouc, Faculty of Medicine and Dentistry
series Biomedical Papers
issn 1213-8118
1804-7521
publishDate 2016-12-01
description Aims: Freezing of gait is a disabling symptom in advanced Parkinson's disease. Positive effects have been suggested with MAO-B inhibitors. We report on an open label clinical study on the efficacy of rasagiline as add-on therapy on freezing of gait and quality of life in patients with Parkinson's disease. Methods: Forty two patients with freezing of gait were treated with 1 mg rasagiline daily as an add-on therapy. Patients were assessed at baseline and after 1, 2 and 3 months of treatment. Freezing of gait severity was assessed using the Freezing of Gait Questionnaire, motor impairment by the modified MDS UPDRS part III, and quality of life using the PDQ-39 questionnaire. Results: Patients treated with rasagiline had a statistically significant decrease in FoG-Q score and modified MDS UPDRS score after 1, 2 and 3 months of therapy. A moderately strong (r = 0.686, P = 0.002) correlation between the effects on mobility and freezing of gait was found. We also observed a statistically significant improvement in global QoL and in the subscales mobility, ADL, stigma and bodily discomfort in patients after 3 months of rasagiline therapy. A significant correlation (r = 0.570, P = 0.02) between baseline FoG-Q score and the baseline score for the PDQ Mobility subscale was found. Conclusion: In our study rasagiline as add-on antiparkinsonian therapy significantly improved mobility, freezing of gait and quality of life. The positive effect on freezing of gait appears to be related to improvement of mobility.
topic parkinson's disease
freezing of gait
rasagiline
url https://biomed.papers.upol.cz/artkey/bio-201604-0015_Effects_of_rasagiline_on_freezing_of_gait_in_Parkinson_s_disease_-_an_open-label_multicenter_study.php
work_keys_str_mv AT frantisekcibulcik effectsofrasagilineonfreezingofgaitinparkinsonsdiseaseanopenlabelmulticenterstudy
AT janbenetin effectsofrasagilineonfreezingofgaitinparkinsonsdiseaseanopenlabelmulticenterstudy
AT egonkurca effectsofrasagilineonfreezingofgaitinparkinsonsdiseaseanopenlabelmulticenterstudy
AT milangrofik effectsofrasagilineonfreezingofgaitinparkinsonsdiseaseanopenlabelmulticenterstudy
AT miloslavdvorak effectsofrasagilineonfreezingofgaitinparkinsonsdiseaseanopenlabelmulticenterstudy
AT denisrichter effectsofrasagilineonfreezingofgaitinparkinsonsdiseaseanopenlabelmulticenterstudy
AT vladimirdonath effectsofrasagilineonfreezingofgaitinparkinsonsdiseaseanopenlabelmulticenterstudy
AT jankothaj effectsofrasagilineonfreezingofgaitinparkinsonsdiseaseanopenlabelmulticenterstudy
AT michalminar effectsofrasagilineonfreezingofgaitinparkinsonsdiseaseanopenlabelmulticenterstudy
AT petervalkovic effectsofrasagilineonfreezingofgaitinparkinsonsdiseaseanopenlabelmulticenterstudy
_version_ 1725134226967232512